Your browser doesn't support javascript.
loading
Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetes.
Desouter, Aster K; Keymeulen, Bart; Demeester, Simke; Van de Velde, Ursule; De Pauw, Pieter; Van Dalem, Annelien; Lapauw, Bruno; De Block, Christophe; Gillard, Pieter; Pipeleers, Daniel G; Gorus, Frans K.
Affiliation
  • Desouter AK; Diabetes Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium; Department of Diabetes and Endocrinology, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium. Electronic address: aster.desouter@uzbrussel.be.
  • Keymeulen B; Diabetes Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium; Department of Diabetes and Endocrinology, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium. Electronic address: bart.keymeulen@uzbrussel.be.
  • Demeester S; Diabetes Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium; Department of Clinical Biology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium. Electronic address: simke.demeester@uzbrussel.be.
  • Van de Velde U; Diabetes Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium; Department of Diabetes and Endocrinology, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium. Electronic address: ursule.vandevelde@uzbrussel.be.
  • De Pauw P; Diabetes Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium. Electronic address: pieter.de.pauw@vub.be.
  • Van Dalem A; Diabetes Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium; Department of Clinical Biology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, Belgium. Electronic address: annelien.vandalem@uzbrussel.be.
  • Lapauw B; Department of Endocrinology, University Hospital Ghent-UGent, Corneel Heymanslaan 10, 9000 Ghent, Belgium. Electronic address: bruno.lapauw@uzgent.be.
  • De Block C; Department of Endocrinology, Diabetology and Metabolism, University of Antwerp-Antwerp University Hospital, Drie Eikestraat 655, 2650 Edegem, Belgium. Electronic address: christophe.deblock@uza.be.
  • Gillard P; Department of Endocrinology, University Hospital Leuven-KU Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: pieter.gillard@uzleuven.be.
  • Pipeleers DG; Diabetes Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium. Electronic address: daniel.pipeleers@vub.be.
  • Gorus FK; Diabetes Research Center, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussels, Belgium; Department of Diabetes and Endocrinology, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium. Electronic address: frans.gorus@uzbrussel.be.
Diabetes Res Clin Pract ; 205: 110974, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37884063
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proinsulin / Diabetes Mellitus, Type 1 Limits: Humans Language: En Journal: Diabetes Res Clin Pract Journal subject: ENDOCRINOLOGIA Year: 2023 Document type: Article Country of publication: Irlanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proinsulin / Diabetes Mellitus, Type 1 Limits: Humans Language: En Journal: Diabetes Res Clin Pract Journal subject: ENDOCRINOLOGIA Year: 2023 Document type: Article Country of publication: Irlanda